- Trying to Block SARS-CoV-2 Transmission With Intranasal VaccinesRubin, RitaJAMA, 2021, 326(17): 1661-1661.
- Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2Lin, Yifan; Sun, Jing; Cao, Xuezhi; Wang, Xiuye; Chen, Xi; Xu, Hairong; Zhao, Jincun*; Fu, Yang-Xin*; Peng, Hua*Cell Discovery, 2022, 8(1): 43.被引 3
- Antiviral Efficacy of Pralatrexate against SARS-CoV-2Joon-Yong, Bae; Gee Eun, Lee; Heedo, Park; Juyoung, Cho; Jeonghun, Kim; Jungmin, Lee; Kisoon, Kim; Jin Il, Kim; Man-Seong, ParkBiomolecules & Therapeutics, 2021.
期刊论文
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
7被引6阅读
